Figure 4.
Dose-dependent hematologic improvement. Mavorixafor produces an initial peak elevation in WBC count, ALC, ANC, and AMC at ∼4 hours postdose. The ALC threshold of 1000 cells per microliter and the ANC threshold of 500 neutrophils per microliter are indicated by dashed lines.

Dose-dependent hematologic improvement. Mavorixafor produces an initial peak elevation in WBC count, ALC, ANC, and AMC at ∼4 hours postdose. The ALC threshold of 1000 cells per microliter and the ANC threshold of 500 neutrophils per microliter are indicated by dashed lines.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal